surgoncoКреативная хирургия и онкологияCreative surgery and oncology2076-30932307-0501Башкирский государственный медицинский университет10.24060/2076-3093-202010-3-233-240surgonco-511Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWSОнкологическая служба в условиях пандемии COVID-19 (обзор литературы)Oncological Care During the Covid-19 Pandemic (Literature Review)https://orcid.org/0000-0003-2047-963XГанцевШ. Х.GantsevSh. Kh.

д.м.н., профессор, кафедра онкологии с курсами онкологии и патологической анатомии ИДПО,

Республика Башкортостан, Уфа

Dr. Sci. (Med.), Prof., Department of Oncology with Courses of Oncology and Pathological Anatomy for Advanced Professional Education,

Ufa

https://orcid.org/0000-0003-3734-2779МеньшиковК. В.MenshikovK. V.

к.м.н., кафедра онкологии с курсами онкологии и патологической анатомии ИДПО, отдел химиотерапии,

Республика Башкортостан, Уфа

Cand. Sci. (Med.), Department of Oncology with Courses of Oncology and Pathological Anatomy for Advanced Professional Education, Department of Chemotherapy,

Ufa

kmenshikov80@bk.ruБашкирский государственный медицинский университетРоссияBashkir State Medical UniversityRussian FederationБашкирский государственный медицинский университет; Республиканский клинический онкологический диспансерРоссияBashkir State Medical University; Republican Clinical Oncological DispensaryRussian Federation202030112020103233240Copyright © Ганцев Ш.Х., Меньшиков К.В., 20202020Ганцев Ш.Х., Меньшиков К.В.Gantsev S.K., Menshikov K.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.surgonco.ru/jour/article/view/511

The aim of the study was to review the international experience in providing oncological care during the COVID-19 pandemic. A literature search was conducted across the Medline, Cochrane Library, Elibrary and PubMed databases to select publications dealing with various aspects reflecting the state and capacity of oncological care during the COVID-19 pandemic. The research sample included 44 articles meeting the selection criteria.

The new coronavirus, known as SARS-Cov-, has become a worldwide threat and a serious health problem in 2020. The pandemic of this infection has had an impact on the management of cancer patients. According to studies conducted in China and the United States, patients with malignancies are at higher risk of severe COVID-19. This has led many oncologists to change their daily cancer treatment practices. An individual approach should be taken when considering the potential risk and beneficial effects of anticancer therapy in the population of cancer patients. A decision to delay the onset of cancer therapy should be made on an individual basis. Strict adherence to sanitary and epidemiological rules, as well as minimization of outpatient visits, can reduce the number of the infected and prevent the spread of the disease among cancer patients. Telemedicine consultations, which allow infectious exposures to be reduced, can be an option of choice. 

COVID‑19коронавирусSARS-CoV‑2пандемиионкологическая службахимиотерапиялучевая терапияхирургияCOVID-19coronavirusSARS-CoV-2pandemicsoncologychemotherapyradiotherapysurgeryReferencesTyrrell D.A., Bynoe M.L. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966;1(7428):76–7. DOI: 10.1016/s0140-6736(66)92364-6Tyrrell D.A., Bynoe M.L. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966;1(7428):76–7. DOI: 10.1016/s0140-6736(66)92364-6Velavan T.P., Meyer C.G. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278–80. DOI: 10.1111/tmi.13383Velavan T.P., Meyer C.G. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278–80. DOI: 10.1111/tmi.13383Cascella M., Rajnik M., Cuomo A., Dulebohn S.C., Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). 2020 Aug 10. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 Jan. PMID: 32150360Cascella M., Rajnik M., Cuomo A., Dulebohn S.C., Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). 2020 Aug 10. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 Jan. PMID: 32150360Kannan S., Shaik Syed Ali P., Sheeza A., Hemalatha K. COVID-19 (Novel Coronavirus 2019) — recent trends. Eur Rev Med Pharmacol Sci. 2020;24(4):2006–11. DOI: 10.26355/eurrev_202002_20378Kannan S., Shaik Syed Ali P., Sheeza A., Hemalatha K. COVID-19 (Novel Coronavirus 2019) — recent trends. Eur Rev Med Pharmacol Sci. 2020;24(4):2006–11. DOI: 10.26355/eurrev_202002_20378Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2020;382(8):727–33. DOI: 10.1056/NEJMoa2001017Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2020;382(8):727–33. DOI: 10.1056/NEJMoa2001017Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–51. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–51. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–207. DOI: 10.1056/ NEJMoa2001316Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–207. DOI: 10.1056/NEJMoa2001316Anastassopoulou C., Russo L., Tsakris A., Siettos C. Data-based analysis, modelling and forecasting of the COVID-19 outbreak. PLoS One. 2020;15(3):e0230405. PMID: 32231374Anastassopoulou C., Russo L., Tsakris A., Siettos C. Data-based analysis, modelling and forecasting of the COVID-19 outbreak. PLoS One. 2020;15(3):e0230405. PMID: 32231374WHO Director General’s opening remarks at the media briefing on COVID-19 — March 11, 2020. World Health Organization. 2020 [cited 2020 March 11]. Available from: www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-at-the-media-briefing-oncovid19—11-march-2020WHO Director General’s opening remarks at the media briefing on COVID-19 — March 11, 2020. World Health Organization. 2020 [cited 2020 March 11]. Available from: www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-at-the-media-briefing-oncovid19—11-march-2020Anderson R.M., Heesterbeek H., Klinkenberg D., Hollingsworth T.D. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395(10228):931–4. DOI: 10.1016/S0140-6736(20)30567-5Anderson R.M., Heesterbeek H., Klinkenberg D., Hollingsworth T.D. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395(10228):931–4. DOI: 10.1016/S0140-6736(20)30567-5Coronavirus disease (COVID-19) Pandemic. World Health Organization. 2020. [cited 2020 March 11]. Available from: https://www.who.int/emergencies/diseases/novel-corona virus-2019Coronavirus disease (COVID-19) Pandemic. World Health Organization. 2020. [cited 2020 March 11]. Available from: https://www.who.int/ emergencies/diseases/novel-corona virus-2019Liang W., Guan W., Chen R., Wang W., Li J., Xu K., et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7. DOI: 10.1016/S1470-2045(20)30096-6Liang W., Guan W., Chen R., Wang W., Li J., Xu K., et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7. DOI: 10.1016/S1470-2045(20)30096-6Dignani M.C., Costantini P., Salgueira C., Jordán R., Guerrini G., Valledor A., et al. Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000Res. 2014;3:221. DOI: 10.12688/F1000RESEARCH.5251.2Dignani M.C., Costantini P., Salgueira C., Jordán R., Guerrini G., Valledor A., et al. Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000Res. 2014;3:221. DOI: 10.12688/ F1000RESEARCH.5251.2Yu J., Ouyang W., Chua M.L.K., Xie C. SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan. JAMA Oncol. 2020;6(7):1108–10. DOI: 10.1001/jamaoncol.2020.0980Yu J., Ouyang W., Chua M.L.K., Xie C. SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan. JAMA Oncol. 2020;6(7):1108–10. DOI: 10.1001/jamaoncol.2020.0980Wang D., Yin Y., Hu C., Liu X., Zhang X., Zhou S., et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020;24(1):188. DOI: 10.1186/s13054-020-02895-6Wang D., Yin Y., Hu C., Liu X., Zhang X., Zhou S., et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020;24(1):188. DOI: 10.1186/s13054-020-02895-6Ганцев Ш.Х., Рустамханов Р.А. Рак во время пандемии короновирусной инфекции COVID-19. Медицинский вестник Башкортостана. 2020;15(3):51–9.Gantsev Sh.Kh., Rustamkhanov R.A Cancer during the pandemic of coronavirus infection COVID-19. Bashkortostan Medical Journal. 2020;15(3):51–9 (In Russ.).Xia Y., Jin R., Zhao J., Li W., Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21(4):e180. DOI: 10.1016/S1470- 2045(20)30150-9Xia Y., Jin R., Zhao J., Li W., Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21(4):e180. DOI: 10.1016/S1470- 2045(20)30150-9Ueda M., Martins R., Hendrie P.C., McDonnell T., Crews J.R., Wong T.L., et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw. 2020:1–4. DOI: 10.6004/jnccn.2020.7560Ueda M., Martins R., Hendrie P.C., McDonnell T., Crews J.R., Wong T.L., et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw. 2020;18(4):366-369.DOI: 10.6004/jnccn.2020.7560Kuderer N.M., Choueiri T.K., Shah D.P., Shyr Y., Rubinstein S.M., Rivera D.R., et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395:1907–18. DOI: 10.1016/S0140-6736(20)31187-9Kuderer N.M., Choueiri T.K., Shah D.P., Shyr Y., Rubinstein S.M., Rivera D.R., et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395:1907–18. DOI: 10.1016/ S0140-6736(20)31187-9Desai A., Warner J., Kuderer N., Thompson M., Painter C., Lyman G., et al. Crowdsourcing a crisis response for COVID-19 in oncology. Nat Cancer. 2020:1–4. DOI: 10.1038/s43018-020-0065-zDesai A., Warner J., Kuderer N., Thompson M., Painter C., Lyman G., et al. Crowdsourcing a crisis response for COVID-19 in oncology. Nat Cancer. 2020;1:473-476. DOI: 10.1038/s43018-020-0065-zVaduganathan M., Vardeny O., Michel T., McMurray J.J., Pfeffer M.A., Solomon S.D. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382(17):1653–9. DOI: 10.1056/NEJMsr2005760Vaduganathan M., Vardeny O., Michel T., McMurray J.J., Pfeffer M.A., Solomon S.D. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382(17):1653–9. DOI: 10.1056/NEJMsr2005760Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80.e8. DOI: 10.1016/j.cell.2020.02.052Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80.e8. DOI: 10.1016/j.cell.2020.02.052Pirofski L., Casadevall A. The damage–response framework as a tool for the physician-scientist to understand the pathogenesis of infectious diseases. J Infect Dis. 2018;218(suppl_1):S7–11. DOI: 10.1093/infdis/jiy083Pirofski L., Casadevall A. The damage–response framework as a tool for the physician-scientist to understand the pathogenesis of infectious diseases. J Infect Dis. 2018;218(suppl_1):S7–11. DOI: 10.1093/infdis/jiy083Hotchkiss R.S., Opal S.M. Activating immunity to fight a foe — a new path. N Engl J Med. 2020;382(13):1270–2. DOI: 10.1056/NEJMcibr1917242Hotchkiss R.S., Opal S.M. Activating immunity to fight a foe — a new path. N Engl J Med. 2020;382(13):1270–2. DOI: 10.1056/NEJMcibr1917242Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–6. DOI: 10.1001/jama.2020.4683Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–6. DOI: 10.1001/jama.2020.4683NCI’s Surveillance and End Results program E. Age and cancer risk. Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/ageNCI’s Surveillance and End Results program E. Age and cancer risk. Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/ageYu J.C., Khodadadi H., Malik A., Davidson B., Salles É.D., Bhatia J., et al. Innate immunity of neonates and infants. Front Immunol. 2018;9:1759. DOI: 10.3389/fimmu.2018.01759Yu J.C., Khodadadi H., Malik A., Davidson B., Salles É.D., Bhatia J., et al. Innate immunity of neonates and infants. Front Immunol. 2018;9:1759. DOI: 10.3389/fimmu.2018.01759Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000;36(4):453–71. DOI: 10.1016/s0959-8049(99)00319-6Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000;36(4):453–71. DOI: 10.1016/s0959-8049(99)00319-6Hanna T.P., Evans G.A., Booth C.M. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17(5):268–70. DOI: 10.1038/s41571-020-0362-6Hanna T.P., Evans G.A., Booth C.M. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17(5):268–70. DOI: 10.1038/s41571-020-0362-6Sharpless N.E. COVID-19 and cancer. Science. 2020;368(6497):1290. DOI: 10.1126/science.abd3377Sharpless N.E. COVID-19 and cancer. Science. 2020;368(6497):1290. DOI: 10.1126/science.abd3377Dong S., Luo C., Hu X., Zhang J., Cai Q., Qian Y., et al. Expert consensus for treating cancer patients during the pandemic of SARS-CoV-2. Front Oncol. 2020;10:1555. DOI: 10.3389/fonc.2020.01555Dong S., Luo C., Hu X., Zhang J., Cai Q., Qian Y., et al. Expert consensus for treating cancer patients during the pandemic of SARS-CoV-2. Front Oncol. 2020;10:1555. DOI: 10.3389/fonc.2020.01555Centers for Disease Control and Prevention. CDC: COVID-19 [cited 2020 Apr 10]. Available from: https://www.cdc.gov/coronavirus/2019-nCoV/index.htmlCenters for Disease Control and Prevention. CDC: COVID-19 [cited 2020 Apr 10]. Available from: https://www.cdc.gov/coronavirus/2019-nCoV/index.htmlAmerican College of Surgeons. ACS: COVID-19 and surgery [cited 2020 Apr 10]. Available from: https://www.facs.org/covid-19/clinical-guidanceAmerican College of Surgeons. ACS: COVID-19 and surgery [cited 2020 Apr 10]. Available from: https://www.facs.org/covid-19/clinicalguidanceASCO coronavirus resources [cited 2020 Apr 9]. Available from: https://www.asco.org/asco-coronavirus-informationASCO coronavirus resources [cited 2020 Apr 9]. Available from: https://www.asco.org/asco-coronavirus-informationMansfield S.A., Abdel-Rasoul M., Terando A.M., Agnese D.M. Timing of breast cancer surgery-how much does it matter? Breast J. 2017;23(4):444–51. DOI: 10.1111/tbj.12758Mansfield S.A., Abdel-Rasoul M., Terando A.M., Agnese D.M. Timing of breast cancer surgery-how much does it matter? Breast J. 2017;23(4):444–51. DOI: 10.1111/tbj.12758Meattini I., Franco P., Belgioia L., Boldrini L., Botticella A., De Santis M.C., et al. Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation’s young oncologists. ESMO Open. 2020;5(2):e000779. DOI: 10.1136/esmoopen-2020-000779Meattini I., Franco P., Belgioia L., Boldrini L., Botticella A., De Santis M.C., et al. Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation’s young oncologists. ESMO Open. 2020;5(2):e000779. DOI: 10.1136/esmoopen-2020-000779Rivera A., Ohri N., Thomas E., Miller R., Knoll M.A. The Impact of COVID-19 on radiation oncology clinics and cancer patients in the U.S. Adv Radiat Oncol. 2020;5(4): 538–43. DOI: 10.1016/j.adro.2020.03.006Rivera A., Ohri N., Thomas E., Miller R., Knoll M.A. The Impact of COVID-19 on radiation oncology clinics and cancer patients in the U.S. Adv Radiat Oncol. 2020;5(4): 538–43. DOI: 10.1016/j.adro.2020.03.006Al-Shamsi H.O., Alhazzani W., Alhuraiji A., Coomes E.A., Chemaly R.F., Almuhanna M., et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An International Collaborative Group. Oncologist. 2020;25(6):e936–45. DOI: 10.1634/theoncologist.2020-0213Al-Shamsi H.O., Alhazzani W., Alhuraiji A., Coomes E.A., Chemaly R.F., Almuhanna M., et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An International Collaborative Group. Oncologist. 2020;25(6):e936–45. DOI: 10.1634/theoncologist.2020-0213Jazieh A.R., Akbulut H., Curigliano G., Rogado A., Alsharm A.A., Razis E., et al. 1678P_PR The impact of COVID-19 pandemic on cancer care: A global collaborative study. Ann Oncol. 2020;31:S1209–10. DOI: 10.1016/j.annonc.2020.08.2325Jazieh A.R., Akbulut H., Curigliano G., Rogado A., Alsharm A.A., Razis E., et al. 1678P_PR The impact of COVID-19 pandemic on cancer care: A global collaborative study. Ann Oncol. 2020;31:S1209–10. DOI: 10.1016/j.annonc.2020.08.2325American Society for Radiation Oncology (ASTRO). COVID-19 recommendations to radiation oncology practices [cited 2020Apr 10]. Available from: https://www.astro.org/Daily-Practice/COVID-19-Recommendations-and-InformationAmerican Society for Radiation Oncology (ASTRO). COVID-19 recommendations to radiation oncology practices [cited 2020Apr 10]. Available from: https://www.astro.org/Daily-Practice/COVID-19-Recommendations-and-InformationAmerican Society for Transplantation and Cellular Therapy (ASTCT). COVID-19 interim patient care guidelines [cited2020 Apr 10]. Available from: https://www.astct.org/connect/astct-response-to-covid-19American Society for Transplantation and Cellular Therapy (ASTCT). COVID-19 interim patient care guidelines [cited2020 Apr 10]. Available from: https://www.astct.org/connect/astct-response-to-covid-19Ohrmalm L., Wong M., Rotzén-Östlund M., Norbeck O., Broliden K., Tolfvenstam T. Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: a matched comparative study. BMC Infect Dis. 2010;10:340. DOI: 10.1186/1471-2334-10-340Ohrmalm L., Wong M., Rotzén-Östlund M., Norbeck O., Broliden K., Tolfvenstam T. Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: a matched comparative study. BMC Infect Dis. 2010;10:340. DOI: 10.1186/1471-2334-10-340Whimbey E., Champlin R.E., Couch R.B., Englund J.A., Goodrich J.M., Raad I., et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis. 1996;22(5):778–82. DOI: 10.1093/clinids/22.5.778Whimbey E., Champlin R.E., Couch R.B., Englund J.A., Goodrich J.M., Raad I., et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis. 1996;22(5):778–82. DOI: 10.1093/clinids/22.5.778European Society for Blood and Marrow Transplantation (EBMT). COVID-19 and BMT [cited 2020 Apr 10]. Available from: https://www.ebmt.org/covid-19-and-bmtEuropean Society for Blood and Marrow Transplantation (EBMT). COVID-19 and BMT [cited 2020 Apr 10]. Available from: https://www.ebmt.org/covid-19-and-bmt

The authors declare that there are no conflicts of interest present.